Drug Trial Radar · NCT02004522
A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)
Last checked: Nov 19, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
319
Actual
Start
Nov 2013
Primary completion
May 19, 2017
Study completion Jun 2021
Sponsor
- Lead sponsor
- SecuraBioIndustry
- Sponsor type
- Industry
- First posted
- Dec 9, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3 clinical trial to examine the efficacy of duvelisib monotherapy versus ofatumumab monotherapy in subjects with relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
DuvelisibDrug
PI3K Inhibitor
OfatumumabDrug
monoclonal antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS)Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 3 years
Locations
92 sites in 11 countries. Site status is shown where the registry gives one.
Site not named
La Jolla, California
Site not named
Denver, Colorado
Site not named
Altamonte Springs, Florida
Site not named
Bonita Springs, Florida
Site not named
Bradenton, Florida
Site not named
Brandon, Florida
Site not named
Cape Coral, Florida
Site not named
Clearwater, Florida
Site not named
Englewood, Florida
Site not named
Fort Myers, Florida
Site not named
Gainesville, Florida
Site not named
Hudson, Florida
Site not named
Inverness, Florida
Site not named
Largo, Florida
Site not named
Naples, Florida
Site not named
New Port Richey, Florida
Site not named
Orange City, Florida
Site not named
Orlando, Florida
Site not named
Port Charlotte, Florida
Site not named
Sarasota, Florida
Site not named
Spring Hill, Florida
Site not named
St. Petersburg, Florida
Site not named
Tampa, Florida
Site not named
Tavares, Florida
Site not named
Venice, Florida
Site not named
Crestview Hills, Kentucky
Site not named
Boston, Massachusetts
Site not named
Boston, Massachusetts
Site not named
St Louis, Missouri
Site not named
Hackensack, New Jersey
Site not named
New Brunswick, New Jersey
Site not named
New York, New York
Site not named
New York, New York
Site not named
Cincinnati, Ohio
Site not named
Fairfield, Ohio
Site not named
Nashville, Tennessee
Site not named
Charlottesville, Virginia
Site not named
Bedford Park, Australia
Site not named
East Melbourne, Australia
Site not named
Melbourne, Australia
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.